9 news items
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals
REGN
4 Jun 24
(NASDAQ:REGN), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
BHVN
REGN
29 May 24
deep in-house expertise in oncology clinical development, ADC chemistry, and complex manufacturing, we believe our diverse and growing ADC portfolio
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines, these students have
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
REGN
17 May 24
by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines
zja5leuzu2qxkp101vd9g3dhom7acae6flhhr2 77arsmjm1lc3wtxtvu
REGN
24 Apr 24
multiple promising and distinct investigational treatment approaches for a diverse array of difficult-to-treat cancers," said George D. Yancopoulos
5jd18mxcluy6oqgcq8e99so1ozk9j17mqe35 xmlpuo1a6ec5jehc
REGN
12 Apr 24
(NASDAQ:REGN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates
0yr8kunqslfw3rdcumci7cg7pxf0wm0t4ftst0sht6yl5uzn
REGN
7 Apr 24
VelociSuite® technologies to develop medicines for patients with diverse blood cancers and rare blood disorders. Our blood
m5pybe3fr0gusi2d0gua1aqfkle5efe25iii58
REGN
26 Mar 24
(NASDAQ:REGN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot
- Prev
- 1
- Next